Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Ucb Pharma SafiledCriticalAmgen Inc
Publication of CR20140081ApublicationCriticalpatent/CR20140081A/es
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Se brindan composiciones y métodos relacionados a epitopos de la proteína esclerostinay los agentes de fijación de esclerostina, tales como anticuerpos capaces de fijarse a la esclerostina.
Proteína de unión a antígeno aislada que se une a linfopoyetina estromal tímica (tslp); composición que comprende una proteína de unión a antígeno que une tslp correspondiente a un anticuerpo humano anti-tslp.